Skip to content

house · Committee report

H. Rept. 119-149

TO DIRECT THE COMMANDANT OF THE COAST GUARD TO UPDATE THE POLICY OF THE COAST GUARD REGARDING THE USE OF MEDICATION TO TREAT DRUG OVERDOSE, AND FOR OTHER PURPOSES

2025-06-06

Committees

Associated legislation

Text

Background and Need for Legislation

The Coast Guard is uniquely positioned as the only armed service capable of performing maritime law enforcement operations.\1\ Under its authorities, the Coast Guard is actively engaged in missions pertaining to drug interdiction.\2\ The Coast Guard performs its counter drug mission within the territorial waters and exclusive economic zone of the United States, on the high seas, and in foreign territorial waters when operating under agreements with allies and partner nations.\3\ --------------------------------------------------------------------------- \1\14 U.S.C. Sec. 522. \2\Id. \3\U.S. Coast Guard, Force Laydown, available at https:// www.uscg.mil/About/Force-Laydown/ #::text=The%20Coast%20Guard%20also%20has,assets%2C%20and%20deployable%2 0 specialized%20forces. --------------------------------------------------------------------------- From fiscal year (FY) 2019 to FY 2024, the Coast Guard intercepted and seized 873.5 metric tons of cocaine, worth approximately $23.6 billion.\4\ More recently, the Coast Guard seized 45,600 pounds of cocaine valued at $517.5 million in March 2025.\5\ --------------------------------------------------------------------------- \4\Interdicting Illicit Drug Trafficking: A View from the Front Lines before the S. Comm. On Commerce, Science, and Transportation, 119th Cong. (Feb. 26, 2025) (testimony of Rear Admiral Adam A. Chamie, United States Coast Guard). \5\Press Release, USCG District 7 Public Affairs, Coast Guard offloads over $517.5 million in illicit drugs interdicted in Eastern Pacific Ocean (Mar. 20,2025), available at https://www.news.uscg.mil/ Press-Releases/Article/4130261/coast-guard-offloads-over-5175-million- in- illicit-drugs-interdicted-in-eastern/. --------------------------------------------------------------------------- Illicit maritime drug shipments are carried by noncommercial means, such as small ``go-fast'' vessels with multiple outboard engines, semisubmersible vessels, fishing vessels, and sailing vessels, as well as by commercial vessels, such as container ships.\6\ The majority of known maritime drug flow is conveyed via noncommercial means through the Western Hemisphere Transit Zone--the waters off the coasts of Central and South America and the Caribbean Sea.\7\ The Coast Guard uses cutters, small boats, aircraft, and unmanned monitoring systems in a layered approach to combat drug cartels as they transport illicit drugs in the maritime domain.\8\ --------------------------------------------------------------------------- \6\United States Coast Guard Report to Congress: Counter-drug operations, (2020), https://www.dhs.gov/sites/default/files/ publications/uscg_-_counter-drug_operations.pdf [hereinafter Counter- Drug Operations]. \7\Id. \8\Id. --------------------------------------------------------------------------- As autonomous maritime technology develops, it is expected that drug smugglers will use unmanned systems to move their illicit shipments.\9\ H.R. 2351 amends the Maritime Drug Law Enforcement Act to remove ambiguity to prosecute cases involving unmanned or autonomous vessels, as well as instances where drugs have been hidden onboard a vessel without the crew's knowledge.\10\ The legislation also ensures the Service will be better prepared to respond to opioid overdoses by requiring an update to Coast Guard policy to ensure the availability of Naloxone on Coast Guard bases and in Coast Guard operational environments to treat opioid overdoses, including those related to Fentanyl. --------------------------------------------------------------------------- \9\Lt. Jasper Campbell and Lt. James Martin, U.S.C.G., The War on Drugs on Autopilot, proceedings (Jan. 2021), available at https:// www.usni.org/magazines/proceedings/2021/january/war-drugs-autopilot. \10\46 U.S.C. Sec. 70503. ---------------------------------------------------------------------------

Hearings

For the purposes of rule XIII, clause 3(c)(6)(A) of the 119th Congress-- The following hearing was used to develop or consider H.R. 2351: The Subcommittee on Coast Guard and Maritime Transportation held a hearing on March 5, 2025, entitled ``America Builds: Coast Guard Acquisitions and Infrastructure'', to examine the Coast Guard recapitalization efforts, including major surface assets including the Offshore Patrol Cutters (OPC) and Polar Security Cutters (PSC), rotary wing aircraft, shoreside infrastructure, and Information Technology (IT). The Subcommittee received testimony from VADM Thomas G. Allan Jr., Acting Deputy Commandant for Operations, USCG, Department of Homeland Security; and Heather MacLeod, Director, Homeland Security and Justice Programs, United States Government Accountability Office (GAO). Legislative History and Consideration H.R. 2351, a bill to direct the Commandant of the Coast Guard to update the policy of the Coast Guard regarding the use of medication to treat drug overdoses, and for other purposes, was introduced in the United States House of Representatives on March 26, 2025, by Representative Addison McDowell and cosponsored by Representative Craig Goldman and Representative Laura Gillen. The bill was referred to the Committee on Transportation and Infrastructure. Within the Committee on Transportation and Infrastructure, H.R. 2351 was referred to the Subcommittee on Coast Guard and Maritime Transportation. The Subcommittee on Coast Guard and Maritime Transportation was discharged from further consideration of H.R. 2351 on April 2, 2025. The Committee considered H.R. 2351 on April 2, 2025, and ordered the measure to be reported to the House with a favorable recommendation, without amendment, by voice vote.

Committee Votes

Clause 3(b) of rule XIII of the Rules of the House of Representatives requires each committee report to include the total number of votes cast for and against on each record vote on a motion to report and on any amendment offered to the measure or matter, and the names of those members voting for and against. No recorded votes were requested for H.R. 2351. Committee Oversight Findings and Recommendations With respect to the requirements of clause 3(c)(1) of rule XIII of the Rules of the House of Representatives, the Committee's oversight findings and recommendations are reflected in this report. New Budget Authority and Tax Expenditures Clause 3(c)(2) of rule XIII of the Rules of the House of Representatives does not apply where a cost estimate and comparison prepared by the Director of the Congressional Budget Office under section 402 of the Congressional Budget Act of 1974 has been timely submitted prior to the filing of the report and is included in the report. Such a cost estimate is included in this report. Congressional Budget Office Cost Estimate With respect to the requirement of clause 3(c)(3) of rule XIII of the Rules of the House of Representatives and section 402 of the Congressional Budget Act of 1974, the Committee has received the enclosed cost estimate for H.R. 2351 from the Director of the Congressional Budget Office: [GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT] H.R. 2351 would direct the Coast Guard (USCG) to carry naloxone and similar overdose medications at all of its facilities, implement a system to track their distribution, and report on those efforts to the Congress. The bill also would codify existing policies prohibiting the manufacture or distribution of controlled substances aboard vessels. Under current law, the USCG is not required to carry naloxone; however, all designated law enforcement units are currently equipped with it. Using information from the Coast Guard, CBO estimates that it would cost less than $500,000 over the 2025-2030 period for the agency to supply naloxone to additional facilities. CBO estimates that maintaining the tracking system and other reporting requirements would cost less than $500,000 over the 2025-2030 period. In total, CBO estimates that implementing H.R. 2351 would cost $1 million over the 2025-2030 period. Any related spending would be subject to the availability of appropriated funds. The CBO staff contacts for this estimate are Kelly Durand and Aaron Krupkin. The estimate was reviewed by H. Samuel Papenfuss, Deputy Director of Budget Analysis. Phillip L. Swagel, Director, Congressional Budget Office. Performance Goals and Objectives With respect to the requirement of clause 3(c)(4) of rule XIII of the Rules of the House of Representatives, the performance goal and objective of this legislation is to provide the Coast Guard necessary authorities to conduct its missions. Duplication of Federal Programs Pursuant to clause 3(c)(5) of rule XIII of the Rules of the House of Representatives, the Committee finds that no provision of H.R. 2351 establishes or reauthorizes a program of the Federal government known to be duplicative of another Federal program, a program that was included in any report from the Government Accountability Office to Congress pursuant to section 21 of Public Law 111-139, or a program related to a program identified in the most recent Catalog of Federal Domestic Assistance. Congressional Earmarks, Limited Tax Benefits, and Limited Tariff Benefits In compliance with clause 9 of rule XXI of the Rules of the House of Representatives, this bill, as reported, contains no congressional earmarks, limited tax benefits, or limited tariff benefits as defined in clause 9(e), 9(f), or 9(g) of the rule XXI. Federal Mandates Statement An estimate of Federal mandates prepared by the Director of the Congressional Budget Office pursuant to section 423 of the Unfunded Mandates Reform Act was not made available to the Committee in time for the filing of this report. The Chairman of the Committee shall cause such estimate to be printed in the Congressional Record upon its receipt by the Committee. Preemption Clarification Section 423 of the Congressional Budget Act of 1974 requires the report of any Committee on a bill or joint resolution to include a statement on the extent to which the bill or joint resolution is intended to preempt state, local, or tribal law. The Committee finds that H.R. 2351 does not preempt any state, local, or tribal law. Advisory Committee Statement No advisory committees within the definition of Section 5(b) of Public Law 92-463 (5 U.S.C. 1004(b)), United States Code, are created by this legislation. Applicability to Legislative Branch The Committee finds that the legislation does not relate to the terms and conditions of employment or access to public services or accommodations within the meaning of section 102(b)(3) of the Congressional Accountability Act (Public Law 104-1). Section-by-Section Analysis of the Legislation Section 1. Controlled substance onboard vessels This section amends the Maritime Drug Law Enforcement Act (Section 70503 of title 46, United Stated Code) to remove ambiguity to prosecute cases involving unmanned or autonomous vessels, as well as instances where drugs have been hidden onboard a vessel without the crew's knowledge. Section 2. Policy and briefing on availability of naloxone to treat opioid overdoses This section requires an update to Coast Guard policy to ensure the availability of Naloxone on Coast Guard bases and in Coast Guard operational environments to treat opioid overdoses, including those related to Fentanyl. Changes in Existing Law Made by the Bill, as Reported In compliance with clause 3(e) of rule XIII of the Rules of the House of Representatives, changes in existing law made by the bill, as reported, are shown as follows (existing law proposed to be omitted is enclosed in black brackets, new matter is printed in italic, existing law in which no change is proposed is shown in roman): Changes in Existing Law Made by the Bill, as Reported In compliance with clause 3(e) of rule XIII of the Rules of the House of Representatives, changes in existing law made by the bill, as reported, are shown as follows (existing law proposed to be omitted is enclosed in black brackets, new matter is printed in italics, and existing law in which no change is proposed is shown in roman): TITLE 46, UNITED STATES CODE * * * * * * * SUBTITLE VII--SECURITY AND DRUG ENFORCEMENT * * * * * * * CHAPTER 705--MARITIME DRUG LAW ENFORCEMENT * * * * * * * Sec. 70503. Prohibited acts (a) Prohibitions.-- [While on board a covered vessel, an] An individual may not knowingly or intentionally-- [(1) manufacture or distribute, or possess with intent to manufacture or distribute, a controlled substance;] (1) manufacture or distribute, possess with intent to manufacture or distribute, or place or cause to be placed with intent to manufacture or distribute a controlled substance on board a covered vessel; (2) destroy (including jettisoning any item or scuttling, burning, or hastily cleaning a vessel), or attempt or conspire to destroy, property that is subject to forfeiture under section 511(a) of the Comprehensive Drug Abuse Prevention and Control Act of 1970 (21 U.S.C. 881(a)) on board a covered vessel ; or (3) conceal, or attempt or conspire to conceal, more than $100,000 in currency or other monetary instruments on the person of such individual while on board a covered vessel or in any conveyance, article of luggage, merchandise, or other container, or compartment of or aboard the covered vessel if that vessel is outfitted for smuggling. (b) Extension Beyond Territorial Jurisdiction.--Subsection (a) applies even though the act is committed outside the territorial jurisdiction of the United States. (c) Nonapplication.-- (1) In general.--Subject to paragraph (2), subsection (a) does not apply to-- (A) a common or contract carrier or an employee of the carrier who possesses or distributes a controlled substance in the lawful and usual course of the carrier's business; or (B) a public vessel of the United States or an individual on board the vessel who possesses or distributes a controlled substance in the lawful course of the individual's duties. (2) Entered in manifest.--Paragraph (1) applies only if the controlled substance is part of the cargo entered in the vessel's manifest and is intended to be imported lawfully into the country of destination for scientific, medical, or other lawful purposes. (d) Burden of Proof.--The United States Government is not required to negative a defense provided by subsection (c) in a complaint, information, indictment, or other pleading or in a trial or other proceeding. The burden of going forward with the evidence supporting the defense is on the person claiming its benefit. (e) Covered Vessel Defined.--In this section the term ``covered vessel'' means-- (1) a vessel of the United States or a vessel subject to the jurisdiction of the United States; or (2) any other vessel if the individual is a citizen of the United States or a resident alien of the United States. * * * * * * * [all]

Source: https://api.congress.gov/v3/committee-report/119/hrpt/149